Barbara Nunes Padovani

Ms. Barbara Nunes Padovani


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2022 in Current Research in Immunology
Verified
Journal Article
Open access
BPBarbara Nunes Padovani
Barbara Nunes Padovani
MAMariana Abrantes Do Amaral
Mariana Abrantes Do Amaral
CFCamila Morales Fénero
Camila Morales Fénero
LPLais Cavalieri Paredes
Lais Cavalieri Paredes
GBGuilherme José Boturra de Barros
Guilherme José Boturra de Barros
TTTatiana Takiishi
Tatiana Takiishi
Little is known about the diversity in immune profile of the different wild type strains of zebrafish (Danio rerio), despite its growing popularity as an animal model to study human diseases and drug testing. In the case of data resulting from modeling human diseases, differences in the background Danio fishes have rarely been taken into consideration when interpreting results and this is potentially problematic, as many studies not even mention the source and strain of the animals. In this study, we hypothesized that different wild type zebrafish strains could present distinct immune traits. To address the differences in immune responses between two commonly used wild type strains of zebrafish, AB and Tübingen (TU), we used an intestinal inflammation model induced by 2,4,6-Trinitrobenzenesulfonic acid (TNBS) and characterized the susceptibility and immune profile in these two strains. Our data demonstrates significant differences in survival between AB and TU strains when exposed to TNBS, suggesting important physiological differences in how these strains respond to inflammatory challenges. We observed that the AB strain presented increased mortality, higher neutrophilic intestinal infiltration, decreased goblet cell numbers and decreased IL-10 expression when exposed to TNBS, compared to the TU strain. In summary, our study demonstrates strain-specific immunological responses in AB and TU animals. Finally, the significant variations in strain-related susceptibility to inflammation and the differences in the immune profile shown here, highlight that the background of each strain need to be considered when utilizing zebrafish to model diseases and for drug screening purposes, thus better immune characterization of the diverse wild type strains of zebrafish is imperative.

Verified
Journal Article
Open access
PDF file
BPBarbara Nunes Padovani
Barbara Nunes Padovani
CFCamila Morales Fénero
Camila Morales Fénero
LPLais Cavalieri Paredes
Lais Cavalieri Paredes
MAMariana Abrantes do Amaral
Mariana Abrantes do Amaral
ODOmar Domínguez-Amorocho
Omar Domínguez-Amorocho
NCNiels Olsen Saraiva Camara
Niels Olsen Saraiva Camara
Cisplatin is an antineoplastic agent used to treat various tumors. In mammals, it can cause nephrotoxicity, tissue damage, and inflammation. The release of inflammatory mediators leads to the recruitment and infiltration of immune cells, particularly neutrophils, at the site of inflammation. Cisplatin is often used as an inducer of acute kidney injury (AKI) in experimental models, including zebrafish (Danio rerio), due to its accumulation in kidney cells. Current protocols in larval zebrafish focus on studying its effect as an AKI inducer but ignore other systematic outcomes. In this study, cisplatin was added directly to the embryonic medium to assess its toxicity and impact on systemic inflammation using locomotor activity analysis, qPCR, microscopy, and flow cytometry. Our data showed that larvae exposed to cisplatin at 7 days post-fertilization (dpf) displayed dose-dependent mortality and morphological changes, leading to a decrease in locomotion speed at 9 dpf. The expression of pro-inflammatory cytokines such as interleukin (il)-12, il6, and il8 increased after 48 h of cisplatin exposure. Furthermore, while a decrease in the number of neutrophils was observed in the glomerular region of the pronephros, there was an increase in neutrophils throughout the entire animal after 48 h of cisplatin exposure. We demonstrate that cisplatin can have systemic effects in zebrafish larvae, including morphological and locomotory defects, increased inflammatory cytokines, and migration of neutrophils from the hematopoietic niche to other parts of the body. Therefore, this protocol can be used to induce systemic inflammation in zebrafish larvae for studying new therapies or mechanisms of action involving neutrophils.

9 March 2021 in Fish and Shellfish Immunology Reports
Verified
Journal Article
Open access
JGJuliana Moreira Mendonça Gomes
Juliana Moreira Mendonça Gomes
TVThalita Marcolan Valverde
Thalita Marcolan Valverde
TMThaís Maria da Mata Martins
Thaís Maria da Mata Martins
ICIves Charlie-Silva
Ives Charlie-Silva
BPBarbara Nunes Padovani
Barbara Nunes Padovani
DGDawidson Assis Gomes
Dawidson Assis Gomes
• The dexamethasone reduced the number of peripheral circulating lymphocytes. • Dexamethasone provided a suitable environment for installation of breast tumor. • Prolonged use of dexamethasone allowed the success of xenografts in zebrafish. • Adult zebrafish as an excellent model to understand the biology of human cancer.